M. Campbell

发表

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low‐grade glioma

L. Coleman, N. Gottardo, T. Walwyn, 2018, Cancer medicine.

Successful matched sibling cord blood transplant for ALL in a child with constitutional mismatch repair deficiency syndrome

M. Campbell, K. Tiedemann, J. Heath, 2016, Bone Marrow Transplantation.

More than Grapes and Bleeding: An Updated Look at Pelvic Rhabdomyosarcoma in Young Women.

Aalia Sachedina, D. Macgregor, S. Grover, 2018, Journal of pediatric and adolescent gynecology.

A Pilot Study on the Utility of Serum Metabolomics in Neuroblastoma Patients and Xenograft Models

A. Weljie, N. Dang, M. Campbell, 2016, Pediatric blood & cancer.

What is the risk of local recurrence after laparoscopic transperitoneal radical nephrectomy in children with Wilms tumours? Analysis of a local series and review of the literature.

Y. Heloury, K. Burnand, M. Campbell, 2018, Journal of pediatric urology.

Growth hormone and targeted oncological agents: Are we stopping children with brain tumours from reaching their true height potential?

D. Eisenstat, J. Hansford, M. Zacharin, 2021, Journal of paediatrics and child health.

Laparoscopic nephrectomy for Wilms' tumor: Can we expand on the current SIOP criteria?

Y. Heloury, K. Burnand, M. Campbell, 2018, Journal of pediatric urology.

Wilms Tumor Associated With the 9q22.3 Microdeletion Syndrome: 2 New Case Reports and a Review of The Literature

Y. Heloury, M. Sullivan, J. Challis, 2019, Journal of pediatric hematology/oncology.

Oral selpercatinib in pediatric patients (pts) with advanced RET-altered solid or primary CNS tumors: Preliminary results from the phase 1/2 LIBRETTO-121 trial.

A. Pappo, D. Ziegler, T. Laetsch, 2021 .

Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma

B. Solomon, J. A. Heath, Alison S. Thomas, 2018, Pediatric blood & cancer.